CMV Infection in Hematopoietic Stem Cell Transplantation: Prevention and Treatment Strategies

被引：0
|
作者：
Niyati Jakharia
Dianna Howard
David J. Riedel
机构：
[1] Stanford University Hospital,Department of Internal Medicine, Section of Infectious Diseases
[2] Wake Forest Baptist Medical Center,Department of Internal Medicine, Section of Hematology
[3] University of Maryland School of Medicine,Oncology
来源：
Current Treatment Options in Infectious Diseases | 2021年 / 13卷
关键词：
CMV infection; Hematopoietic stem cell transplantation; Letermovir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：123 / 140
页数：17
相关论文
共 50 条
  • [31] Lymphotropic herpesvirus DNA detection in patients with active CMV infection - a possible role in the course of CMV infection after hematopoietic stem cell transplantation
    Zawilinska, Barbara
    Kopec, Jolanta
    Szostek, Slawa
    Piatkowska-Jakubas, Beata
    Skotnicki, Aleksander B.
    Kosz-Vnenchak, Magdalena
    MEDICAL SCIENCE MONITOR, 2011, 17 (08): : CR432 - CR441
  • [32] Cost Effectiveness of Letermovir in Prevention of Clinically Significant CMV Infection in CMV Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (04) : 12 - 13
  • [33] Incidence of CMV Reactivation and Infection in Children and Adolescents Following Allogeneic Hematopoietic Stem Cell Transplantation in High CMV Exposure Population
    Hussein, Ayad Ahmed
    Al-Antary, Eman T.
    Al-Zaben, Abdulhadi I.
    Frangoul, Haydar A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S253 - S253
  • [34] Prevention Strategies Against CMV-Infection After Liver Transplantation
    Belarmino, Armin
    Kniepeiss, Daniela
    Fleischhacker, Marie-Therese
    Riedl, Regina
    Mandl-Pohl, Astrid
    Mueller, Helmut
    Schemmer, Peter
    TRANSPLANTATION, 2022, 106 (09) : S650 - S650
  • [35] PREVENTION STRATEGIES AGAINST CMV-INFECTION AFTER LIVER TRANSPLANTATION
    Belarmino, Armin
    Kniepeiss, Daniela
    Fleischhacker, Marie-Therese
    Riedl, Regina
    Mandl-Pohl, Astrid
    Mueller, Helmut
    Schrem, Harald
    Iberer, Florian
    Tscheliessnigg, Karlheinz
    Schemmer, Peter
    TRANSPLANT INTERNATIONAL, 2021, 34 : 36 - 36
  • [36] Incidence of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell recipients at low risk of CMV infection
    Mori, T
    Okamoto, S
    Watanabe, R
    Yamazaki, R
    Tsukada, Y
    Nagayama, H
    Ishida, A
    Ikeda, Y
    BONE MARROW TRANSPLANTATION, 2002, 29 (12) : 1005 - 1006
  • [37] Oral valganciclovir is safe and effective as preemptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation
    Ayala, E
    Greene, J
    Sandin, R
    Perkins, J
    Field, T
    Tate, C
    Goldstein, SC
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 31 - 31
  • [38] The Efficacy and Safety of Cidofovir in Salvage Therapy for CMV Infection in the Patients with Haploid Hematopoietic Stem Cell Transplantation
    Yu, Guo-Pan
    Yin, Zhao
    Fan, Zhiping
    Huang, Fen
    Xu, Na
    Jiang, Ling
    Wang, Zhixiang
    Xuan, Li
    Liu, Qifa
    Feng, Ru
    Sun, Jing
    BLOOD, 2019, 134
  • [39] Incidence of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell recipients at low risk of CMV infection
    T Mori
    S Okamoto
    R Watanabe
    R Yamazaki
    Y Tsukada
    H Nagayama
    A Ishida
    Y Ikeda
    Bone Marrow Transplantation, 2002, 29 : 1005 - 1006
  • [40] Cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation: significant progress, but many unresolved problems
    Busca, Alessandro
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (04) : 383 - 385
12345